| Bid Price | 0.60p | High Price | 0.62p |
|---|
| Ask Price | 0.62p | Low Price | 0.60p |
|---|
| Open Price | 0.60p | Spread | 3.23% |
|---|
| Prev Close | 0.60p | Volume | 7,547,871 |
|---|
Tissue Regenix Group PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jun 18, 2021 | 0.60 | 0.62 | 0.60 | 0.61 | 7,547,871 |
| Jun 17, 2021 | 0.61 | 0.62 | 0.60 | 0.60 | 12,269,314 |
| Jun 16, 2021 | 0.62 | 0.64 | 0.60 | 0.62 | 8,565,301 |
| Jun 15, 2021 | 0.63 | 0.64 | 0.61 | 0.63 | 10,866,576 |
| Jun 14, 2021 | 0.63 | 0.64 | 0.60 | 0.63 | 8,680,708 |
Tissue Regenix Group PLC Information
| Name | Tissue Regenix Group PLC | Epic | TRX |
|---|
| ISIN | GB00B5SGVL29 | Currency | GBX |
|---|
| Type | Equity | Trading Segment | ASQ1 |
|---|
| Record Status | Active | Trading Status | Closed |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 75,000 | Prev Close | 0.60p |
|---|
| Shares in Issue | 7.03 bn | Market Cap | £42.90 m |
|---|
| PE Ratio | | Div per Share | n/a |
|---|
| Div Yield | 0 | Div Cover | n/a |
|---|
| EPS | £-0.00 | EPS Growth (%) | n/a |
|---|
| PEG | n/a | DPS Growth (%) | 0 |
|---|
| ROCE | -0.192064 | Quick Ratio | 3.736745 |
|---|
| Current Ratio | 6.156911 |
|---|
Tissue Regenix Group PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/05/21 | BUY | Daniel Lee | CEO | 2,068,750 @ £0.01 | £14,274.00 |
| 10/05/21 | BUY | David Cocke | FD | 2,821,000 @ £0.01 | £18,054.00 |
| 06/01/21 | BUY | Trevor Phillips | NED | 2,777,770 @ £0.01 | £15,000.00 |
| 23/06/20 | EXR | Shervanthi Homer-Vanniasinkam | NED | 1,388,222 @ £0.00 | £63.00 |
| 05/06/20 | PLAC | Jonathan Glenn | NED | 40,000,000 @ £0.00 | £100,000.00 |
Tissue Regenix Group PLC News
